L-Dopa decarboxylase modulates autophagy in hepatocytes and is implicated in dengue virus-caused inhibition of autophagy completion.

Autolysosomes Autophagic flux Autophagy Catecholamines DENV Dengue virus L-Dopa decarboxylase (DDC) Serotonin Viral proliferation

Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 03 06 2023
revised: 13 09 2023
accepted: 24 09 2023
medline: 27 11 2023
pubmed: 2 10 2023
entrez: 1 10 2023
Statut: ppublish

Résumé

The enzyme L-Dopa Decarboxylase (DDC) synthesizes the catecholamine dopamine and the indolamine serotonin. Apart from its role in the brain as a neurotransmitter biosynthetic enzyme, DDC has been detected also in the liver and other peripheral organs, where it is implicated in cell proliferation, apoptosis, and host-virus interactions. Dengue virus (DENV) suppresses DDC expression at the later stages of infection, during which DENV also inhibits autophagosome-lysosome fusion. As dopamine affects autophagy in neuronal cells, we investigated the possible association of DDC with autophagy in human hepatocytes and examined whether DDC mediates the relationship between DENV infection and autophagy. We performed DDC silencing/overexpression and evaluated autophagic markers upon induction of autophagy, or suppression of autophagosome-lysosome fusion. Our results showed that DDC favored the autophagic process, at least in part, through its biosynthetic function, while knockdown of DDC or inhibition of DDC enzymatic activity prevented autophagy completion. In turn, autophagy induction upregulated DDC, while autophagy reduction by chemical or genetic (ATG14L knockout) ways caused the opposite effect. This study also implicated DDC with the cellular energetic status, as DDC silencing reduced the oxidative phosphorylation activity of the cell. We also report that upon DDC silencing, the repressive effect of DENV on the completion of autophagy was enhanced, and the inhibition of autolysosome formation did not exert an additive effect on viral proliferation. These data unravel a novel role of DDC in the autophagic process and suggest that DENV downregulates DDC expression to inhibit the completion of autophagy, reinforcing the importance of this protein in viral infections.

Identifiants

pubmed: 37778471
pii: S0167-4889(23)00175-1
doi: 10.1016/j.bbamcr.2023.119602
pii:
doi:

Substances chimiques

Dopa Decarboxylase EC 4.1.1.-
Dopamine VTD58H1Z2X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119602

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Vassilina Tsopela (V)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Evangelos Korakidis (E)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Despoina Lagou (D)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Katerina I Kalliampakou (KI)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Raphaela S Milona (RS)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Eirini Kyriakopoulou (E)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

George Mpekoulis (G)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Ioanna Gemenetzi (I)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Elli-Anna Stylianaki (EA)

Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, 16672 Athens, Greece.

Constantinos D Sideris (CD)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Aggelina Sioli (A)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Dionysis Kefallinos (D)

School of Electrical Engineering and Computer Science, National Technical University of Athens, 157 73 Athens, Greece.

Diamantis C Sideris (DC)

Section of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 157 01 Athens, Greece.

Vassilis Aidinis (V)

Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, 16672 Athens, Greece.

Aristides G Eliopoulos (AG)

Department of Biology, School of Medicine, NKUA, 115 27 Athens, Greece; Center of Basic Research, Biomedical Research Foundation Academy of Athens, 115 27 Athens, Greece.

Konstantinos Kambas (K)

Laboratory of Molecular Genetics, Department of Immunology, Hellenic Pasteur Institute, 115 21 Athens, Greece.

Dido Vassilacopoulou (D)

Section of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 157 01 Athens, Greece.

Niki Vassilaki (N)

Laboratory of Molecular Virology, Hellenic Pasteur Institute, 115 21 Athens, Greece. Electronic address: nikiv@pasteur.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH